ASSIIST
Research type
Research Study
Full title
Assessing the impact of InPen smart MDI system in type 2 diabetes
IRAS ID
346494
Contact name
Pratik Choudhary
Contact email
Sponsor organisation
University of Leicester
ISRCTN Number
ISRCTN78298012
Duration of Study in the UK
1 years, 6 months, 1 days
Research summary
Background to the research
Type 2 diabetes accounts for more than 90% of patients with diabetes and if inadequately treated, leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on healthcare systems.
Although new therapies have been very valuable, a significant number of people still require insulin therapy. Many of these people struggle to achieve target glucose levels, putting them at risk of complications. Patients struggle between the risks of running too high or too low.
While those with T1D often have access to intensive structured education through programs such as DAFNE on how to adjust therapy, this is often not available for the patients with T2D on insulin.
Studies showed that the use of technology such as connected pens and continuous glucose monitoring systems can help achieving the target glycaemic range.
Smart MDI systems can use settings programmed by the healthcare professionals to provide dose advise and improve outcomes.
REC name
London - Dulwich Research Ethics Committee
REC reference
25/LO/0282
Date of REC Opinion
19 Jun 2025
REC opinion
Further Information Favourable Opinion